Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 401–500 of 1,001
Engaging plasticity: Differentiation therapy in solid tumors
Bar-Hai, N., & Ishay-Ronen, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944773 · Cited by 35
“In recent years, our perception of EMT in cancer progression has evolved from a simple binary model into a multi-step model with intermediate transition states on the spectrum between epithelial to mesenchymal, characterized by high plasticity (Polyak and Weinberg, 2009; Tsai and Yang, 2013; Nieto et al., 2016; Aiello…”
BackgroundChen, C.-Y., Yang, S.-H., Chang, P.-Y., Chen, S., Nieh, S., Huang, W.-Y., Lin, Y., & Lee, O. K. (2024) · Cells · doi:10.3390/cells13161334 · Cited by 35
“The EMT is recognized as a fundamental process in embryonic development and cancer progression, and it enables epithelial cells to acquire mesenchymal traits [43].”
BackgroundRoychowdhury, T., McNutt, S. W., Pasala, C., Nguyen, H. T., Thornton, D. T., Sharma, S., Botticelli, L., Digwal, C. S., Joshi, S., Yang, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53178-5 · Cited by 35
Prediction of Cancer Stem Cell Fate by Surface-Enhanced Raman Scattering Functionalized Nanoprobes
Haldavnekar, R., Vijayakumar, S. C., Venkatakrishnan, K., & Tan, B. (2020) · ACS Nano · doi:10.1021/acsnano.0c06104 · Cited by 35
Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer
Tanabe, S., Quader, S., Ono, R., Cabral, H., Aoyagi, K., Hirose, A., Yokozaki, H., & Sasaki, H. (2020) · Cancers · doi:10.3390/cancers12123833 · Cited by 35
“Abundant molecules and networks are involved in EMT process, while core EMT transcription factors have been defined as SNAI1/2, ZEB1/2 and TWIST2 [8,9].”
BackgroundCai, L., Hu, C., Yu, S., Liu, L., Zhao, J., Zhao, Y., Lin, F. Y., Du, X., Yu, Q., & Xiao, Q. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.582274 · Cited by 35
Hadadi, É., & Acloque, H. (2021) · Endocrine Related Cancer · doi:10.1530/erc-20-0390 · Cited by 35
Zhu, H., Lü, H., Xiao, Y., Guo, Y., Guo, Y., Huang, Y., 刘晓冬, Shan, Y., Bai, Y., & Lin, X. (2021) · Aging · doi:10.18632/aging.203725 · Cited by 35
Breast cancer circulating tumor cells with mesenchymal features—an unreachable target?
Topa, J., Grešner, P., Zaczek, A. J., & Markiewicz, A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04064-6 · Cited by 35
Qiu, F., Liu, Q., Xia, Y., Jin, H., Lin, Y., & Zhao, X. J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02175-3 · Cited by 35
“EMT occurs in both physiological and pathological conditions and can be triggered by a conserved set of inducing signals, downstream effectors and transcriptional regulators, contributing to functional changes in cell migratory and invasive potential [20].”
BackgroundRole of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs
Takahashi, M., Hasegawa, Y., Maeda, K., Kitano, M., & Taniguchi, N. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10041-3 · Cited by 35
Sun, S., Liu, Y., Zhou, M., Wen, J., Xue, L., Han, S., Liang, J., Wang, Y., Wei, Y., Yu, J., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00788-5 · Cited by 35
“The epithelial to mesenchymal transition of cancer cells modifies the expression of various genes that are crucial for metastatic properties [44, 45].”
BackgroundMonoubiquitination in Homeostasis and Cancer
Chen, Y., Zhou, D., Yao, Y., Sun, Y., Yao, F., & Ma, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115925 · Cited by 35
“In response to stimulation by TGF-β, the E3 ligase SMURF1 monoubiquitinates phosphorylated p120-catenin, leading to the dissociation of AJs, EMT, and breast cancer metastasis [138].”
BackgroundInfluentialS100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
Low, R. R. J., Fung, K. Y., Gao, H., Preaudet, A., Dagley, L. F., Yousef, J. M., Lee, B., Emery‐Corbin, S. J., Nguyen, P. M., Larsen, R. H., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01126-z · Cited by 35
“This concept has now shifted to reflect a continuum of partial EMT states with overlapping transcriptional features found in multiple cancers, including PDAC [4, 11].”
BackgroundInfluentialBai, Y., Götz, C., Chincarini, G., Zhao, Z., Slaney, C. Y., Boath, J., Furic, L., Angel, C. M., Jane, S. M., Phillips, W. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37161-0 · Cited by 35
Waryah, C. B., Cursons, J., Foroutan, M., Pflueger, C., Wang, E., Molania, R., Woodward, E., Sorolla, A., Wallis, C. J. D., Moses, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202301802 · Cited by 35
Self-citationGupta, S., Lytvynchuk, L. M., Ardan, T., Studenovská, H., Sharma, R., Faura, G., Eide, L., Verma, R. S., Znaor, L., Erceg, S., et al. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad039 · Cited by 34
Cochard, M., Ledoux, F., & Landkocz, Y. (2020) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2020.1816238 · Cited by 34
Coelho, B. P., Fernandes, C. F. D. L., Boccacino, J. M., Souza, M. C. D. S., Melo-Escobar, M. I., Alves, R. N., Prado, M. B., Iglesia, R. P., Cangiano, G., Mazzaro, G. L. R., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.597743 · Cited by 34
“In tumor cells, EMT is activated in metastasis and invasion, which allows cells to detach from the basement membrane and connect with other cells, extravasating from its initial location and invading adjacent tissues (6, 9).”
BackgroundТаширева, Л. А., Savelieva, O. E., Grigoryeva, E. S., Nikitin, Y. V., Denisov, E. V., Vtorushin, S. V., Zavyalova, M. V., Чердынцева, Н. В., & Михайлович, П. В. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052504 · Cited by 34
“It is believed that, as a rule, the transition from the expression of cytokeratins to vimentin is observed after the completion of EMT [9].”
BackgroundInfluentialVafaizadeh, V., Buechel, D., Rubinstein, N., Kalathur, R. K. R., Bazzani, L., Saxena, M. T., Valenta, T., Hausmann, G., Cantù, C., Basler, K., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02016-9 · Cited by 34
Self-citationGarinet, S., Didelot, A., Denize, T., Perrier, A., Beinse, G., Leclère, J.-B., Oudart, J., Gibault, L., Badoual, C., Pimpec‐Barthes, F. L., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01568-7 · Cited by 34
Marangoni effect and cell spreading
Pajić‐Lijaković, I., & Milivojevic, M. S. (2022) · European Biophysics Journal · doi:10.1007/s00249-022-01612-1 · Cited by 34
“The SS of 0.3 Pa causes the EMT in epithelial ovarian cancer (Rizvi et al.”
BackgroundInfluentialWang, Q., Karvelsson, S. T., Kotronoulas, A., Guðjónsson, Þ., Halldórsson, S., & Rolfsson, Ó. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100185 · Cited by 34
MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
Damane, B. P., Hull, R., Reis, R. M., Agbor, C. A., Ambele, M. A., Mulaudzi, T. V., & Dlamini, Z. (2022) · Genes · doi:10.3390/genes13020244 · Cited by 34
“miRNAs have been shown to regulate epithelial to mesenchymal transition (EMT) [5], a process whereby epithelial cells undergo biological processes that allow them to take on the phenotype of mesenchymal stem cells and adopt their enhanced migratory ability, invasive capacity and increased ability to resist apoptosis […”
BackgroundZou, H., Yang, Z., Chan, Y. S., Yeung, S.-K. A., Alam, M. K., Si, T., Xu, T., & Yang, M. (2022) · iScience · doi:10.1016/j.isci.2022.103917 · Cited by 34
“Collective migration, a critical process for tumor metastasis, is a result of incomplete epithelial-mesenchymal transition (EMT) (Yang et al., 2020).”
BackgroundKang, N., Xie, X., Zhou, X., Wang, Y., Chen, S., Qi, R., Liu, T., & Jiang, H. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02257-2 · Cited by 34
“EMT plays a significant role in CC progression by contributing to cell migration and tumor metastasis, promoting the occurrence of tumor stem cells characteristics, reducing apoptosis and senescence, facilitating drug resistance [6].”
BackgroundYe, Y., Zhang, X., Su, D., Ren, Y., Cheng, F., Yao, Y., Shi, G., Ji, Y., Chen, S., Shi, P., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03157-8 · Cited by 34
“EMT is not an extreme phenotype of epithelial and mesenchyme, but an intermediate state in which epithelial/stromal cells are mixed [61].”
BackgroundFan, C., González‐Prieto, R., Kuipers, T. B., Vertegaal, A. C. O., van Veelen, P. A., Mei, H., & ten Dijke, P. (2023) · Science Signaling · doi:10.1126/scisignal.adf1947 · Cited by 34
Martínez-Iglesias, O. A., Casas-Pais, A., Castosa, R., Díaz-Díaz, A., Roca‐Lema, D., Concha, Á., Cortés, Á., Gago, F., & Figueroa, A. (2020) · Cancers · doi:10.3390/cancers12051340 · Cited by 33
“On the other hand, it was reported that early stages of EMT involve a post-translational downregulation of E-cadherin, whereas loss of E-cadherin via transcriptional repression is a late event in EMT [49,50].”
BackgroundThe Role of Exosomes in Thyroid Cancer and Their Potential Clinical Application
Feng, K., Ma, R., Zhang, L., Li, H., Tang, Y., Du, G., Niu, D., & Yin, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596132 · Cited by 33
“Epithelial-Mesenchymal Transition (EMT) in TC EMT is a cellular process during which epithelial cells acquire mesenchymal phenotypes and behaviors following the downregulation of proteins that indicate epithelial features (82).”
BackgroundWang, F., Sun, H., Zuo, B., Shi, K., Zhang, X., Zhang, C., & Sun, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-95827-5 · Cited by 33
UM-6 induces autophagy and apoptosis via the Hippo-YAP signaling pathway in cervical cancer
Wang, D., He, J., Dong, J., Wu, S., Liu, S., Zhu, H., & Xu, T. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.020 · Cited by 33
Epithelial to mesenchymal transition during mammalian neural crest cell delamination
Zhao, R., & Trainor, P. A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.02.018 · Cited by 34
“In medio stat virtus”: Insights into hybrid E/M phenotype attitudes
Canciello, A., Cerveró-Varona, A., Peserico, A., Mauro, A., Russo, V., Morrione, A., Giordano, A., & Barboni, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1038841 · Cited by 33
“Intriguingly, P-cad and Slug are indicated to play pivotal roles in collective cell migration, a specific features of hybrid E/M cells (Liao and Yang 2020; Noronha et al., 2021).”
BackgroundMechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells
Tessmann, J. W., Rocha, M. R., & Morgado‐Díaz, J. A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30361 · Cited by 33
“Cellular changes observed in this process include cytoskeletal remodeling, establishment of a front‐rear polarity, and reorganization of the extracellular matrix.(56) This cellular program is coordinated by the EMT‐inducing transcription factors (EMT‐TFs), including SNAIL, SLUG, ZEB, and TWIST.”
BackgroundZhang, Y., Zhang, X., Huang, X., Tang, X., Zhang, M., Li, Z., Hu, X., Zhang, M., Wang, X., & Yan, Y. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03239-1 · Cited by 33
“Introduction Epithelial-to-mesenchymal transition (EMT) is the reversible recoding of epithelial cells to mesenchymal cells [1, 2] (Fig.”
BackgroundEmerging roles of endoplasmic reticulum stress in the cellular plasticity of cancer cells
Wang, H., & Mi, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1110881 · Cited by 33
“EMP refers to the ability of tumor cells to differentiate along the epithelial-mesenchymal spectrum and exhibit various intermediate hybrid E/M states (21, 22).”
BackgroundLiu, X., Qin, H., Zhang, L., Jia, C., Chao, Z., Qin, X., Zhang, H., & Chen, C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102647 · Cited by 33
An In Vitro Approach to Model EMT in Breast Cancer
Isert, L., Mehta, A., Loiudice, G., Oliva, A., Roidl, A., & Merkel, O. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097757 · Cited by 33
“It is well accepted that a switch in cellular intermediate filament (IF) usage from cytokeratin to vimentin occurs during EMT [3,29].”
BackgroundContribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Strippoli, R., Niayesh‐Mehr, R., Adelipour, M., Khosravi, A., Cordani, M., Zarrabi, A., & Allameh, A. (2024) · Cancers · doi:10.3390/cancers16040807 · Cited by 33
“These complexes include Partitioning defective (PAR), Crumbs, and Scribble complexes, which exhibit a cortically asymmetric distribution [62,67,71].”
BackgroundInfluentialSundararajan, V., Pang, Q. Y., Choolani, M. A., & Huang, R. Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00213 · Cited by 33
Self-citationZhang, Y., Zhang, R., Liang, F., Zhang, L., & Liang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.598801 · Cited by 34
Molecular aspects of brain metastases in breast cancer
Tomasik, B., Bieńkowski, M., Górska, Z., Gutowska, K., Kumięga, P., Jassem, J., & Duchnowska, R. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102521 · Cited by 33
Ferrero, R., Rainer, P. Y., Rumpler, M., Russeil, J., Zachara, M., Pezoldt, J., van Mierlo, G., Gardeux, V., Saelens, W., Alpern, D., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.017 · Cited by 32
Tan, Y., Qin, S., Zhang, Z., Liu, Y., Zhou, L., Li, B., Nice, E. C., Zhang, Y., & Jing, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70009 · Cited by 32
ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation
Lu, D., Aji, G., Li, G., Li, Y., Fang, W., Zhang, S., Yu, R., Jiang, S., Gao, X., Jiang, Y., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci180242 · Cited by 32
Clinical applications of circulating tumor cells in metastasis and therapy
Yang, C., Liu, C., Xia, C., & Fu, L. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01733-y · Cited by 32
“Epithelial–mesenchymal plasticity (EMP) refers to the ability of cells to adopt mixed E/M characteristics and interconvert between intermediate E/M phenotypic states [15].”
Lioulia, E., Mokos, P., Panteris, E., & Dafou, D. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13111 · Cited by 32
Li, G., Guo, B., Wang, H., Lin, G.-T., Lan, T., Ying, H., & Xu, J. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09668-z · Cited by 32
A panel of emerging EMT genes identified in malignant mesothelioma
Wu, L., Amjad, S., Yun, H., Mani, S. A., & de Perrot, M. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-04973-x · Cited by 32
Self-citationPersister cell plasticity in tumour drug resistance
McDonald, P. C., & Dedhar, S. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.11.003 · Cited by 32
Self-citationESRP1 controls biogenesis and function of a large abundant multiexon circRNA
Liu, D., Dredge, B. K., Bert, A. G., Pillman, K. A., Toubia, J., Guo, W., Dyakov, B. J. A., Migault, M., Conn, V. M., Conn, S. J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1138 · Cited by 32
“EMT confers motility on cells to allow tissue remodelling during embryogenesis, but can be recapitulated in part (called epithelial plasticity) by cancer cells to promote tissue invasion and metastasis ( 42 ).”
BackgroundSelf-citationKim, W., Zhou, Y., Simonenko, V., Shahi, A., Malikzay, A., Long, S. Z., Xu, J. J., Lu, A., Horng, J.-H., Wu, C., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcad059 · Cited by 32
“In later stage tumors responsive to TGF β , the cytokine can also induce Epithelial Mesenchymal Transition (EMT) ( 32 ), which has also been shown to contribute to chemo-resistance and immune evasion ( 33 ).”
BackgroundShahsavandi, Y., Banaeian, F., Jafarinia, M., Nasri, F., & Shapoori, S. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102715 · Cited by 31
The Epigenetic landscape of Circulating tumour cells
Vasantharajan, S. S., Eccles, M. R., Rodger, E. J., Pattison, S. T., McCall, J. L., Gray, E. S., Calapre, L., & Chatterjee, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188514 · Cited by 31
Lineage Plasticity in Cancer: The Tale of a Skin-Walker
Thankamony, A. P., Subbalakshmi, A. R., Jolly, M. K., & Nair, R. (2021) · Cancers · doi:10.3390/cancers13143602 · Cited by 31
“A process similar to EndMT is epithelial-mesenchymal transition (EMT): a reversible change in molecular, morphological and functional traits of epithelial cells to more mesenchymal traits during the metastatic cascade and/or in the emergence of drug resistance [62,64].”
BackgroundZheng, X., Wang, P., Li, L., Yu, J., Yu, C., Xu, L., Li, L., Dai, F., Feng, L., Zou, H., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.678670 · Cited by 31
Wu, Y., You, X., Lin, Q., Xiong, W., Guo, Y., Huang, Z., Dai, X., Chen, Z., Mei, S., Long, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.791269 · Cited by 31
“Abnormal activation of these targets can promote the biological processes of prostate cancer, such as proliferation, metastasis, inflammation, and angiogenesis, and further aggravate the malignant process of prostate cancer (Yang et al., 2020).”
BackgroundKyriakopoulou, K., Kefali, E., Piperigkou, Z., Riethmüller, C., Greve, B., Franchi, M., Götte, M., & Karamanos, N. K. (2021) · FEBS Journal · doi:10.1111/febs.16240 · Cited by 31
TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling
Iyengar, P. V., Marvin, D. L., Lama, D., Tan, T. Z., Suriyamurthy, S., Xie, F., van Dinther, M., Mei, H., Verma, C. S., Zhang, L., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-1029 · Cited by 31
“SLUG is a well-studied EMT-transcription factor that has been described to play roles in cadherin switching and malignancy in bladder cancer progression[19].”
BackgroundInfluentialSynaptotagmin-13 orchestrates pancreatic endocrine cell egression and islet morphogenesis
Bakhti, M., Bastidas-Ponce, A., Tritschler, S., Czarnecki, O., Tarquis-Medina, M., Nedvedova, E., Jaki, J., Willmann, S. J., Scheibner, K., Cota, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31862-8 · Cited by 32
Sahu, S. K., Agirre, E., Inayatullah, M., Mahesh, A., Tiwari, N., Lavin, D. P., Singh, A. P., Strand, S., Diken, M., Luco, R. F., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00971-3 · Cited by 31
Biomechanics of cancer stem cells
Chen, X., Tang, K., Li, X., Zhang, C., Xin, Y., Li, K., & Tan, Y. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220014 · Cited by 31
Yamashiro, Y., Ramirez, K., NAGAYAMA, K., Hattori, N., Liu, Y.-Y., Matsunaga, S., Tomita, S., Kubota, Y., & Yanagisawa, H. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac190 · Cited by 31
Lobb, R. J., Visan, K. S., Wu, L., Norris, E. L., Hastie, M. L., Everitt, S., Yang, I. A., Bowman, R., Siva, S., Larsen, J. E., et al. (2023) · Communications Biology · doi:10.1038/s42003-022-04350-4 · Cited by 31
Horny, K., Sproll, C. K., Peiffer, L., Furtmann, F., Gerhardt, P., Gravemeyer, J., Stoecklein, N. H., Spassova, I., & Becker, J. C. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04102-w · Cited by 31
“Thus, expression of EMT-related genes and their regulating transcription factors is highly heterogeneous, even within one cancer entity, between patients, in different lesions from one patient, and between individual cancer cells within one lesion [4, 9].”
BackgroundInfluentialEmerging Roles of Mesenchymal Stem/Stromal-Cell-Derived Extracellular Vesicles in Cancer Therapy
Nicodemou, A., Bernatova, S., Čeháková, M., & Danišovič, Ľ. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051453 · Cited by 31
“Emerging evidence has indicated the fundamental role of EVs in the EMT mediating metastasis [147,148].”
BackgroundDual role of Snail1 as transcriptional repressor and activator
de Herreros, A. G. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189037 · Cited by 31
miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation
Zareifar, P., Ahmed, H. M., Ghaderi, P., Farahmand, Y., Rahnama, N., Esbati, R., Moradi, A., Yazdani, O., & Sadeghipour, Y. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3931 · Cited by 31
“27 These changes lead to the migration of cancer cells and invasion into nearby tissues and then spread to distant areas.”
BackgroundEpithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors
Ακρίδα, Ι., Mulita, F., Plachouri, K., Benetatos, N., Maroulis, I. C., & Papadaki, H. H. (2023) · Medical Oncology · doi:10.1007/s12032-023-02259-4 · Cited by 30
Chen, R., Zhu, S., Zhao, R., Liu, W., Jin, L., Ren, X., & He, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1402514 · Cited by 30
The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance
Heissig, B., Salama, Y., Takahashi, S., Okumura, K., & Hattori, K. (2021) · Cancers · doi:10.3390/cancers13051014 · Cited by 30
“In the early stages of metastasis, epithelial cells decrease the expression of cell–cell junction molecules at the primary tumor site and become motile [66,67].”
BackgroundTan, X., Banerjee, P., Liu, X., Jiang, Y. L., Lee, S., Ahn, Y., Creighton, C. J., & Kurie, J. M. (2021) · JCI Insight · doi:10.1172/jci.insight.153948 · Cited by 30
Meng, Z., Chen, Y., Wu, W., Yan, B., Zhang, L., Chen, H., Meng, Y., Liang, Y., Yao, X., & Luo, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.754645 · Cited by 30
Li, G., Suzuki, H., Ohishi, T., Asano, T., Tanaka, T., Yanaka, M., Nakamura, T., Yoshikawa, T., Kawada, M., Kaneko, M. K., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5221 · Cited by 30
“E‑cadherin downregulation sometimes leads to epithelial‑to‑mesenchymal transition and an increase in tumorigenicity (54).”
Paul, I., Bolzan, D., Youssef, A., Gagnon, K. A., Hook, H., Karemore, G., Oliphant, M. U. J., Lin, W., Liu, Q., Phanse, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36122-x · Cited by 30
Local Delivery of Glabridin by Biomolecular Microneedle to Accelerate Infected Wound Healing
Chen, Z., Hu, T., Wang, R., Huang, B., Tu, L., Wang, G., Li, C., Dong, B., Wang, Z., & Hu, W. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302470 · Cited by 30
Potential role of epithelial–mesenchymal transition induced by periodontal pathogens in oral cancer
Ma, Y., Yu, Y., Yin, Y., Wang, L., Yang, H., Luo, S., Zheng, Q., Pan, Y., & Zhang, D. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18064 · Cited by 30
“20 Notably, EMT is not a binary process in cancer progression, for cancer cells are capable of expressing different levels of both epithelial and mesenchymal markers, which is referred to as partial, incomplete or hybrid EMT states.”
BackgroundClinical impact of epithelial–mesenchymal transition for cancer therapy
Mukerjee, N., Nag, S., Bhattacharya, B., Alexiou, A. T., Mirgh, D., Mukherjee, D., Adhikari, M. D., Anand, K., Muthusamy, R., Gorai, S., et al. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.260 · Cited by 30
Zhang, J., Thorikay, M., van der Zon, G., van Dinther, M., & ten Dijke, P. (2020) · Journal of Visualized Experiments · doi:10.3791/61830 · Cited by 31
Assembly, dynamics and remodeling of epithelial cell junctions throughout development
Mira-Osuna, M., & Borgne, R. L. (2024) · Development · doi:10.1242/dev.201086 · Cited by 29
Pérez-Moreno, E., Oyanadel, C., de la Peña, A., Hernández, R., Pérez-Molina, F., Metz, C., González, A., & Soza, A. (2024) · Biological Research · doi:10.1186/s40659-024-00490-5 · Cited by 30
“The diversity of epithelial changes is illustrated by a consensus list of core events as indicators of EMT [59].”
BackgroundInfluentialJin, H. K., Park, S., Lee, J., Park, H., Jeong, M., Lee, H., Cho, J., & Lee, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.029 · Cited by 29
Ye, Y., Yu, S., Guo, T., Zhang, S., Shen, X., & Han, G. (2024) · Biomolecules · doi:10.3390/biom14121523 · Cited by 29
“Betty Hay first proposed the concept of epithelial-to-mesenchymal transformation in 1967 while studying embryogenes [10].”
Ciccone, G., Gonzalez‐Oliva, M. A., Versaevel, M., Cantini, M., Vassalli, M., Salmerón‐Sánchez, M., & Gabriele, S. (2025) · Advanced Science · doi:10.1002/advs.202408635 · Cited by 29
Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
Agnoletto, C., Caruso, C., & Garofalo, C. (2021) · Cancers · doi:10.3390/cancers13092189 · Cited by 29
Sohn, M.-H., Kim, S. I., Shin, J.-Y., Kim, H. S., Chung, H. H., Kim, J., Lee, M., & Seo, J. (2021) · Genes · doi:10.3390/genes12071103 · Cited by 34
“Specifically, the EMT index was calculated for each sample based on the geometric mean of transcripts per million (TPM) values for five core EMT-TFs (TWIST1, SNAI1, SNAI2, ZEB1, and ZEB2) and 33 EMT-related TFs (KLF4, GSC, TCF7L2, ALX1, GATA6, RUNX2, TCF3, SOX4, FOXC2, NFKB1, KLF2, KLF6, TBX3, TCF4, PRRX1, HOXB7, JUN,…”
BackgroundMethodThe Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
Cessna, H., Baritaki, S., Zaravinos, A., & Bonavida, B. (2022) · Cancers · doi:10.3390/cancers14194596 · Cited by 29
Yin, Z., & Wang, L. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2180155 · Cited by 29
“Notably, the invasion and migration abilities of tumour cells are mainly acquired through the process of EMT [61].”
BackgroundThe Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing
Gross, C., Guérin, L.-P., Socol, B. G., Germain, L., & Guérin, S. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713182 · Cited by 29
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
Lorenzo-Sanz, L., Lopez-Cerda, M., da Silva-Diz, V., Artés, M. H., Llop, S., Penin, R. M., Bermejo, J. O., González‐Suárez, E., Esteller, M., Viñals, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49718-8 · Cited by 30
Tissue-reactive zonation of mesenchymal-like phenotypes in human glioblastoma
Albiach, A. M., Janusauskas, J., Jacobsen, J. K., Kapustová, I., Karamzadeh, R., Kvedaraite, E., Hu, L., Franck, M. C. M., García, M. R., Fernández-García, D., et al. (2026) · Med · doi:10.1016/j.medj.2026.101228 · Cited by 29
Shi, X., Li, Q., Zhang, C., Pei, H., Wang, G., Zhou, H., Fan, L., Yang, K., Jiang, B., Wang, F., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01083-0 · Cited by 29
Cuadrado, A., Cazalla, E., Bach, A., Bathish, B., Naidu, S. D., DeNicola, G. M., Dinkova-Kostova, A. T., Fernández-Ginés, R., Grochot-Przeczek, A., Hayes, J. D., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103569 · Cited by 28
“However, it has been reported that the treatment of ulcerative colitis patients with indigo naturalis, which is used in patients refractory to TNF therapy, activated both the aryl hydrocarbon receptor and NRF2, increasing expression of antioxidant genes and inhibiting ferroptosis [157].”
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 28
Zhang, H., Wang, H., Jing, Z., Liu, B., Wang, X., Li, Y., Luo, H.-M., Lv, H., Tao, X., Timashev, P. S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1567524 · Cited by 28
Distinct roles of tumor associated mutations in collective cell migration
Lee, R., Vitolo, M. I., Losert, W., & Martin, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89130-6 · Cited by 28
Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer
Opławski, M., Nowakowski, R., Średnicka, A., Ochnik, D., Grabarek, B. O., & Boroń, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071520 · Cited by 28
“An epithelial–mesenchymal transition (EMT) is a molecular and phenotypic process of reprogramming polarized and immobile epithelial cells into mobile mesenchymal cells, the consequence of which is an increase in mobility and also invasion [1,2].”
BackgroundDefining epithelial-mesenchymal transitions in animal development
Sheng, G. (2021) · Development · doi:10.1242/dev.198036 · Cited by 28
Self-citation
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.